BE894829A - IMPROVEMENTS IN TUMOR DETECTION - Google Patents

IMPROVEMENTS IN TUMOR DETECTION

Info

Publication number
BE894829A
BE894829A BE0/209345A BE209345A BE894829A BE 894829 A BE894829 A BE 894829A BE 0/209345 A BE0/209345 A BE 0/209345A BE 209345 A BE209345 A BE 209345A BE 894829 A BE894829 A BE 894829A
Authority
BE
Belgium
Prior art keywords
tumor detection
tumor
detection
Prior art date
Application number
BE0/209345A
Other languages
French (fr)
Inventor
T H Adams
G S David
S E Halpern
Original Assignee
Hybritech Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc, Univ California filed Critical Hybritech Inc
Publication of BE894829A publication Critical patent/BE894829A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1066Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BE0/209345A 1981-10-27 1982-10-27 IMPROVEMENTS IN TUMOR DETECTION BE894829A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31528681A 1981-10-27 1981-10-27

Publications (1)

Publication Number Publication Date
BE894829A true BE894829A (en) 1983-02-14

Family

ID=23223718

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/209345A BE894829A (en) 1981-10-27 1982-10-27 IMPROVEMENTS IN TUMOR DETECTION

Country Status (18)

Country Link
JP (1) JPS58135820A (en)
AT (1) AT392004B (en)
BE (1) BE894829A (en)
CA (1) CA1202892A (en)
CH (1) CH653040A5 (en)
DE (1) DE3239410A1 (en)
DK (1) DK164682C (en)
ES (2) ES8404857A1 (en)
FI (1) FI82379C (en)
FR (1) FR2515046B1 (en)
GB (1) GB2109407B (en)
IL (1) IL67068A0 (en)
IT (1) IT1153857B (en)
LU (1) LU84441A1 (en)
NL (1) NL8204108A (en)
NO (1) NO169947C (en)
SE (1) SE8206073L (en)
ZA (1) ZA827806B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
CA1225930A (en) * 1982-06-07 1987-08-25 Otto A. Gansow Metal chelate conjugated monoclonal antibodies
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
SE8401946L (en) * 1983-04-08 1984-11-13 Kureha Chemical Ind Co Ltd ANTIBODY AGAINST HUMAN PROSTATACANCES
SE8401945L (en) * 1983-04-08 1984-11-13 Kureha Chemical Ind Co Ltd ANTIBODY AGAINST CANCER IN THE URIN BLADE OF HUMAN
JPS59199636A (en) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk Radioactive diagnostic agent and production thereof
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4732864A (en) * 1983-10-06 1988-03-22 E. I. Du Pont De Nemours And Company Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules
JPS60201260A (en) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd Myocardial myosin diagnosing agent
JP2507982B2 (en) * 1984-04-10 1996-06-19 武田薬品工業株式会社 Method for producing human carcinoembryonic antigen-reactive monoclonal antibody
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4824986A (en) * 1985-04-26 1989-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Metal chelate protein conjugate
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4925804A (en) * 1986-06-17 1990-05-15 Baxter International Inc. Interligand metal transfer assay
US4831175A (en) * 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5246692A (en) * 1986-09-05 1993-09-21 The United States Of America As Represented By The Secretary Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
FR2604092B1 (en) * 1986-09-19 1990-04-13 Immunotech Sa IMMUNOREACTIVES FOR TARGETING ANIMAL CELLS FOR VISUALIZATION OR DESTRUCTION IN VIVO
CA1340014C (en) * 1986-10-27 1998-08-25 Bryan Michael Longenecker Carcinoma-marking monoclonal antibodies elicited with synthetic asialo-gmi antigen
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US4838274A (en) * 1987-09-18 1989-06-13 Air Products And Chemicals, Inc. Perfluoro-crown ethers in fluorine magnetic resonance imaging
US5217704A (en) * 1987-11-06 1993-06-08 Abbott Laboratories Methods and materials for the preparation of metal labelled antibody solutions
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US4867962A (en) * 1988-02-26 1989-09-19 Neorx Corporation Functionally specific antibodies
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US4988496A (en) * 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5688488A (en) * 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
EP0590766B1 (en) * 1992-07-31 2000-02-02 Australian Nuclear Science And Technology Organisation Hydroxylaryl containing aminocarboxylic acid chelating agents
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US7521531B2 (en) 1996-08-28 2009-04-21 Immunomedics, Inc. Methods for the purification of stable radioiodine conjugates
US6558669B1 (en) 1996-08-28 2003-05-06 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis
US6663866B1 (en) 1996-08-28 2003-12-16 Immunomedics, Inc. Stable radioiodine conjugates and methods for their synthesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands
US4311688A (en) * 1979-10-29 1982-01-19 Serono Laboratories Inc. Composition and method for cancer detection in humans
JPH036125B2 (en) * 1980-03-03 1991-01-29 Miruton Deebitsudo Goorudenbaagu

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710730A1 (en) * 1987-03-31 1988-10-20 Schering Ag SUBSTITUTED COMPLEX ILLUMINATORS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
FI823633A0 (en) 1982-10-25
NO169947B (en) 1992-05-18
NO823530L (en) 1983-04-28
FR2515046B1 (en) 1985-11-29
GB2109407B (en) 1985-12-18
LU84441A1 (en) 1983-06-13
IT1153857B (en) 1987-01-21
ES516797A0 (en) 1984-05-16
FI823633L (en) 1983-04-28
FI82379B (en) 1990-11-30
CH653040A5 (en) 1985-12-13
DK164682C (en) 1992-12-21
DK474182A (en) 1983-04-28
SE8206073L (en) 1983-04-28
GB2109407A (en) 1983-06-02
FR2515046A1 (en) 1983-04-29
NL8204108A (en) 1983-05-16
IT8223932A0 (en) 1982-10-26
JPH0564130B2 (en) 1993-09-14
ZA827806B (en) 1983-08-31
ES529310A0 (en) 1985-05-16
DE3239410A1 (en) 1983-05-19
FI82379C (en) 1991-03-11
AT392004B (en) 1991-01-10
SE8206073D0 (en) 1982-10-26
ES8505482A1 (en) 1985-05-16
IL67068A0 (en) 1983-02-23
NO169947C (en) 1992-08-26
CA1202892A (en) 1986-04-08
JPS58135820A (en) 1983-08-12
DK164682B (en) 1992-08-03
ES8404857A1 (en) 1984-05-16
DE3239410C2 (en) 1991-12-19
ATA391682A (en) 1990-07-15

Similar Documents

Publication Publication Date Title
BE894829A (en) IMPROVEMENTS IN TUMOR DETECTION
DK156019C (en) Back side PROJEKTIONSSKAERM
GB2089617B (en) Ultrasonic sensing
DK163757C (en) SLOT
MX152265A (en) IMPROVEMENTS IN A COMPRESSOR HEATER
GB2100861B (en) Ultrasonic sensing
IT1155933B (en) MICROPROCESSOR
MX155309A (en) IMPROVEMENTS IN HIGHER SCALE
FI820427L (en) FOERBINDNING FOER IN I VARANDRA GRIPANDE METALL- ELLER PLASTPROFILER
DE3266597D1 (en) BIPHASE DETECTOR
ES516683A0 (en) "IMPROVEMENTS IN TACHOGRAPHES".
MX159636A (en) IMPROVEMENTS IN A GERMINATOR
BE890080A (en) IMPROVEMENTS IN GASOGENES
DK249982A (en) SLOT
AR222268A1 (en) IMPROVEMENTS IN BOILERS
BR6100127U (en) IMPROVEMENTS IN VENEZIANAS
BR8103306A (en) IMPROVEMENTS IN SIFAO
AR226470A1 (en) IMPROVEMENTS IN HARVESTER-THRESHING MACHINES
MX151379A (en) IMPROVEMENTS IN TICKETS
BR6101818U (en) CASHIER
BR6101494U (en) CASHIER
PT7217U (en) CASHIER
ES498512A0 (en) IMPROVEMENTS IN LLA-VES MILLING-COPIING MACHINES
BR8106808A (en) IMPROVEMENTS IN AND REGARDING THE SEEDER-FERTILIZER
BR6100332U (en) WALLET

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: HYBRITECH INC.

Effective date: 19951031

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Effective date: 19951031